Pharmigene Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	35.02	92.34	68.53	76.86	104.29	212.77
Short-Term Investments	40.18	31.96	38.81	118.73	134.8	84.71
Trading Asset Securities	-	34.34	53.43	-	-	-
Cash & Short-Term Investments	75.2	158.64	160.78	195.59	239.09	297.48
Cash Growth	-39.61%	-1.33%	-17.80%	-18.19%	-19.63%	202.55%
Accounts Receivable	41.48	12.87	25.66	27.43	17.31	12.67
Other Receivables	0.54	0.68	0.49	1.15	0.03	0.12
Receivables	42.02	13.55	26.15	28.58	17.34	12.79
Inventory	49.72	53.68	27.44	28.57	18.71	17.46
Prepaid Expenses	8.8	21.3	17.92	5.39	10.65	9.09
Other Current Assets	2.34	3.07	21.7	0.4	0.3	0.27
Total Current Assets	178.09	250.25	253.99	258.54	286.09	337.08
Property, Plant & Equipment	546.27	593.89	559.95	28.35	36.73	30.57
Long-Term Investments	51.37	16.3	86.11	67.18	70.81	63.4
Other Intangible Assets	15.07	13.44	14.07	14.03	15.96	6.3
Long-Term Deferred Tax Assets	-	-	-	-	-	0.02
Other Long-Term Assets	173.33	129.28	132.85	16.17	9.54	12.54
Total Assets	964.12	1,003	1,047	384.27	419.12	449.91
Accounts Payable	18.1	14.42	7.95	7.19	2.88	2.88
Accrued Expenses	9.29	10.18	11.37	10.06	7.92	6.92
Current Portion of Long-Term Debt	12.17	12.94	-	-	-	-
Current Portion of Leases	3.65	3.85	6.53	5.35	6.99	6.89
Current Income Taxes Payable	-	-	-	-	-	1.48
Current Unearned Revenue	2.28	3.72	2.01	9.07	2.74	3.9
Other Current Liabilities	4.98	7.39	8.85	6.64	4.31	1.73
Total Current Liabilities	72.47	52.51	36.72	38.3	24.84	23.81
Long-Term Debt	577.61	597.46	559.4	-	-	-
Long-Term Leases	1.55	2.23	5.16	4.09	7.75	14.74
Long-Term Deferred Tax Liabilities	-	-	-	-	0.01	-
Other Long-Term Liabilities	2.17	1.88	1.57	2.13	4.3	1.8
Total Liabilities	653.79	654.08	602.85	44.52	36.9	40.35
Common Stock	504.65	504.65	504.65	434.65	434.65	434.65
Additional Paid-In Capital	-	105	105	-	-	45.07
Retained Earnings	-187.67	-251.34	-172.73	-100.09	-57.37	-79.01
Comprehensive Income & Other	-6.66	-9.25	7.18	5.19	4.95	8.85
Shareholders' Equity	310.33	349.06	444.1	339.75	382.22	409.56
Total Liabilities & Equity	964.12	1,003	1,047	384.27	419.12	449.91
Total Debt	616.97	616.49	571.1	9.43	14.74	21.63
Net Cash (Debt)	-541.77	-457.84	-410.32	186.16	224.35	275.85
Net Cash Growth	-	-	-	-17.02%	-18.67%	246.69%
Net Cash Per Share	-10.74	-9.07	-9.02	4.28	5.16	8.15
Filing Date Shares Outstanding	50.47	50.47	50.47	43.47	43.47	43.47
Total Common Shares Outstanding	50.47	50.47	50.47	43.47	43.47	43.47
Working Capital	105.62	197.74	217.27	220.24	261.25	313.27
Book Value Per Share	6.15	6.92	8.80	7.82	8.79	9.42
Tangible Book Value	295.26	335.63	430.04	325.72	366.26	403.26
Tangible Book Value Per Share	5.85	6.65	8.52	7.49	8.43	9.28
Land	260.61	284.6	284.6	-	-	-
Buildings	261.48	281.35	250.31	8.67	-	-
Machinery	58.51	53.11	39.53	35.16	46.37	27.26
Construction In Progress	3.17	3.17	13.11	-	-	-
Leasehold Improvements	-	-	-	-	8.3	7
Order Backlog	-	-	-	-	-	3.9

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.